NEUROCRINE BIOSCIENCES INC (NBIX) Revenue 2016–2025
NEUROCRINE BIOSCIENCES INC (NBIX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$2.9BFY2025 · since FY2016: $15.0M → $2.9B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.9B | +21.4% |
| FY2024 | $2.4B | +24.8% |
| FY2023 | $1.9B | +26.8% |
| FY2022 | $1.5B | +31.3% |
| FY2021 | $1.1B | +8.4% |
| FY2020 | $1.0B | +32.7% |
| FY2019 | $788.1M | +74.7% |
| FY2018 | $451.2M | +179.2% |
| FY2017 | $161.6M | +977.5% |
| FY2016 | $15.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NBIX financial trends
NBIX Net incomeNBIX Net marginNBIX Gross profitNBIX Gross marginNBIX Operating incomeNBIX Operating marginNBIX Operating cash flowNBIX Free cash flowNBIX Capital expendituresNBIX Return on equityNBIX Stock buybacksNBIX Dividends paidNBIX Total assetsNBIX Total liabilitiesNBIX Shareholders’ equityNBIX overview →